Understand the potential impact of biosimilars through provocative presentations from Biocon, India and Boehringer Ingelheim, Germany. Learn how to achieve significant cost savings by implementing lean manufacturing in the keynote presentation from the high tech industry plus case study. Evaluate strategies for outsourcing and the economics of orphan drugs. Gain insight into pre-competitive research in logistics and manufacturing including long-range demand planning, plus hear strategies for production planning when demand is uncertain. Improve the competitiveness and quality of your product via reports on financial advantages of quality by design, analyses of disposables, and supply chain management.

• Strategic Planning for Biopharmaceuticals: Challenges for a Maturing Industry
• Production Planning for Cost-Efficient Manufacture when Demand is Uncertain
• Improving Competitiveness and Quality of Biopharmaceuticals

Advisory Board

• Joanne T. Beck, Ph.D., Plant Manager, Abbott Bioresearch Center
• Wolfgang Berthold, Ph.D., Chief Technical Officer, Biogen Idec
• William P. Botha, Director of Manufacturing, Baxter Healthcare Corporation
• Andrew Cockshott, Ph.D., Manager, Manufacturing Science and Technology, Eli Lilly and Co.
• Jon T. Conary, Ph.D., Senior Director, Manufacturing, Human Genome Sciences, Inc.
• Howard L. Levine, Ph.D., President, BioProcess Technology Consultants, Inc.
• Duncan Low, Ph.D., Scientific Executive Director, Process Development, Amgen Inc.
• Rhona M. O'Leary, Ph.D., Director, BioProcess Development, Genentech, Inc.

View the Agenda

• Day One - Morning
• Day One - Afternoon
• Day Two - Morning
• Day Two - Afternoon
• Day Three

View the Other Tracks

• Scaling Up from Bench through Commercialization
• Cell Culture & Upstream Processing
• Recovery & Purification